Search Results 191-200 of 307 for ❗어코드가입코드 【위너보증.com / 가입코드 9122】 올인구조대 ❗

  1. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

    Luspatercept is approved by the U.S. Food and Drug Administration (FDA) for patients with anemia who require RBC blood transfusions with very low- to ...

  2. Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM - Mayo Clinic

    This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non- ...

  3. Clinical Trials - TVS Pilot Study

    The purpose of this study is to compare detection rates of endometrial cancer-specific methylated DNA markers in vaginal fluid collected via tampon v. vaginal ...

  4. Federalwide Assurance (FWA) - Mayo Clinic Research

    Institutional Review Board at Mayo Clinic: Federalwide Assurance outlines principles to protect the rights and welfare of research subjects.

  5. Donate to Mayo Clinic

    With your support, we can continue providing top-notch patient care, groundbreaking research, and education to train the next generation of healthcare workers.

  6. SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM - Mayo Clinic

    The primary purpose of this study is to assess the long-term safety and tolerability of mavacamten in participants with Hypertrophic Cardiomyopathy (HCM) ...

  8. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    The purpose of this study is to evaluate progression-free survival at 12 months in patients undergoing treatment with EV/Pembro and CC/U with or without MDT.

  9. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic - Mayo Clinic

    A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic.

  10. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability profile of JK07, administered intravenously, according to protocol-defined dosing regimen.